Spectrum Pharmaceuticals (NASDAQ: SPPI)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.190 | -0.060 | 0.1300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Spectrum Pharmaceuticals (NASDAQ: SPPI) through any online brokerage.
Other companies in Spectrum Pharmaceuticals’s space includes: Graphite Bio (NASDAQ:GRPH), Jounce Therapeutics (NASDAQ:JNCE), Humanigen (NASDAQ:HGEN), Sesen Bio (NASDAQ:SESN) and Olema Pharmaceuticals (NASDAQ:OLMA).
The latest price target for Spectrum Pharmaceuticals (NASDAQ: SPPI) was reported by B. Riley Securities on Monday, March 21, 2022. The analyst firm set a price target for 4.00 expecting SPPI to rise to within 12 months (a possible 354.55% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Spectrum Pharmaceuticals (NASDAQ: SPPI) is $0.88 last updated June 24, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on December 28, 2012 to stockholders of record on December 18, 2012.
Spectrum Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Spectrum Pharmaceuticals.
Spectrum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.